Listed

Processa Pharmaceuticals, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Sep 8, 2017 and accepted by EDGAR at Sep 8, 2017, 15:29 ET.

Share

Management's discussion and analysis

As filed, 19,404 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis should be read in conjunction with the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section and audited consolidated financial statements and related notes thereto included in our 2015 Annual Report on Form 10-K, and with the unaudited condensed consolidated financial statements and related notes thereto presented in this Quarterly Report on Form 10-Q.

Forward-Looking Statements

The statements contained in this report that are not historical facts are forward-looking statements that represent management’s beliefs and assumptions based on currently available information. Forward-looking statements include the information concerning our possible or assumed future results of operations, business strategies, need for financing, competitive position, potential growth opportunities, potential operating performance improvements, ability to retain and recruit personnel, the effects of competition and the effects of future legislation or regulations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words “believes,” “intends,” “may,” “should,” “anticipates,” “expects,” “could,” “plans,” or comparable terminology or by discussions of strategy or trends. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we cannot give any assurances that these expectations will prove to be correct. Such statements by their nature involve risks and uncertainties that could significantly affect expected results, and actual future results could differ materially from those described in such forward-looking statements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

risks associated with the asphalt repair industry, including competition, increases in wages, labor relations, energy and fuel costs, actual and threatened pandemics, actual and threatened terrorist attacks, and downturns in domestic and international economic and market conditions;

risks associated with the asphalt repair industry, including changes in laws or regulations, increases in taxes, rising insurance premiums, costs of compliance with environmental laws and other governmental regulations;

the availability and terms of financing and capital and the general volatility of securities markets;

changes in the competitive environment in the asphalt repair industry;

risks related to natural disasters;

litigation; and

other risk factors discussed in the 2015 Annual Report on Form 10-K, filed by the Company with the Securities and Exchange Commission.

Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those expected. We disclaim any intention or obligation to update publicly or revise such statements whether as a result of new information, future events or otherwise.

Overview and Basis of Presentation

Heatwurx, Inc. was incorporated under the laws of the State of Delaware on March 29, 2011 as Heatwurxaq, Inc. and subsequently changed its name to Heatwurx, Inc. on April 15, 2011.

We are an asphalt preservation and repair, equipment company. Our innovative, and eco-friendly hot-in-place recycling process corrects surface distresses within the top 3 inches of existing pavement by heating the surface material to a temperature between 325° and 375° Fahrenheit with our electrically powered infrared heating equipment, mechanically loosening the heated material with our processor/tiller attachment that is optimized for producing a seamless repair, and mixing in additional recycled asphalt pavement and a binder (asphalt-cement), and then compacting repaired area with a vibrating roller or compactor. We consider our equipment to be eco-friendly as the Heatwurx process reuses and rejuvenates distressed asphalt, uses recycled asphalt pavement for filler material, eliminates travel to and from asphalt batch plants, and extends the life of the roadway. We believe our equipment, technology and processes provide savings over other processes that can be more labor and equipment intensive.

Our hot-in-place recycling process and equipment was selected by the Technology Implementation Group of the American Association of State Highway Transportation Officials (“AASHTO TIG”) as an “additionally Selected Technology” for the year 2012. We develop, manufacture and intend to sell our unique and innovative and eco-friendly equipment to federal, state and local agencies as well as contractors for the repair and rehabilitation of damaged and deteriorated asphalt surfaces.

In January 2014, we acquired Dr. Pave, LLC a service company offering asphalt repair and restoration utilizing the Heatwurx asphalt repair technology. Dr. Pave, offered asphalt restoration services to municipalities and the commercial sector in southern California.

Effective July 22, 2014, we established a new entity named Dr. Pave Worldwide LLC to house our franchise program providing franchisees with the exclusive Heatwurx equipment and processing. We formally launched our franchise sales program throughout the U.S. in the third quarter of 2014; however, to date, no franchises have been sold. The Company has decided not to renew its franchise registrations throughout the U.S. do to the extensive costs. During 2015, we began offering license agreements, which grants a license of all Heatwurx equipment and supplies and the use of the Heatwurx intellectual property within a specified territory. We have one licensee as of September 30, 2016.

We are no longer receiving financial support and we do not believe we will be able to obtain financing from another source. We do not believe we are able to achieve a level of revenues adequate to support our cost structure. Do to the slow growth in the service sector and the high cost of the franchise registrations, we discontinued the operations of Dr. Pave, LLC and Dr. Pave Worldwide LLC. In addition, we significantly scaled back operations to maintain only a minimal level of operations necessary to support our licensee and look for potential merger candidates. The Company sold the remaining equipment and inventory to the licensee during the nine months of 2016. Based upon the Company’s current financial position, the Company does not believe it will be able to satisfy the mandatory principal payments in 2016. The Company will work with the lenders to explore extension or conversion options. There is no guarantee the lenders will accommodate our requests. As of September 30, 2016; principal in the amount of $962,361 is outstanding and payable within six months under the secured notes. These notes are secured by all the assets of the Company, including intellectual property rights. We are in default on the notes, and as a result the Company’s assets may be foreclosed upon.

The issues described above raise substantial doubt about the Company’s ability to continue as a going concern. It is our intention to move forward as a public entity and to seek potential merger candidates. If the Company fails to merge or be acquired by another company, we will be required to terminate all operations.

Section 107 of the JOBS Act provides that an “emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. However, we are choosing to “opt out” of such extended transition period, and as a result, we will comply with new or revised standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Section 107 of the JOBS Act provides that our decision to opt out of the extended transition period for complying with new or revised accounting standards is irrevocable.

Results of operations

The following discussion of the financial condition and results of operations should be read in conjunction with the financial statements included herewith. This discussion should not be construed to imply that results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future.

For the three months ended September 30, 2016 compared to the three months ended September 30, 2015

For the three months ended September 30, 2016, our net loss was $68,333 including loss from discontinued operations of $42, compared to a net loss of $295,743 including losses from discontinued operations of $73,359 for the same period of 2015. Further description of these losses is provided below.

Revenue

The Company recognized no revenue in the three months ended September 30, 2016 and $58,165 during the three months ended September 30, 2015. The Company does not anticipate any future revenue from equipment sales during 2016.

Cost of goods sold

The Company had no cost of goods sold during the three months ended September 30, 2016 and $42,618 during the three months ended September 30, 2015.

Selling, general and administrative

Selling, general and administrative expenses decreased to approximately $4,000 for the three months ended September 30, 2016 from approximately $84,000 for the three months ended September 30, 2015. The decrease in selling, general and administrative expenses is principally due to the significant reduction in operating activities which include a decrease in travel and office expenses of approximately $45,000 which includes commercial insurance, rent and other expenses; a decrease in employee expenses of approximately $18,000; a decrease in legal and investor relations expenses of $12,000; and a decrease in bad debt expense of $5,000.

Impairment on assets held for sale

As part of the strategy to keep operations running at minimum capacity, in 2015 we chose to sell assets or return collateralized assets to relieve the debt, which are not critical to the continued operations. We reclassified these non-critical assets for sale from equipment or inventory and recognized an impairment loss when the carrying amount of the assets exceeds its fair value. During the three months ended September 30, 2015 we recognized an impairment on assets held for sale of approximately $55,000.

Research and Development

The Company had research and development costs during the three months ended September 30, 2016 of approximately $600; a decrease from approximately $1,700 from the three months ended September 30, 2015, as a result of a reduction in legal patent costs, a decrease in manufacturing research and development costs, and a decrease in consulting fees.

For the nine months ended September 30, 2016 compared to the nine months ended September 30, 2015

For the nine months ended September 30, 2016, our net loss was $245,158 including income from discontinued operations of $1,214, compared to a net loss of $2,991,461 including losses from discontinued operations of $336,988 for the same period of 2015. Further description of these losses is provided below.

Revenue

The Company recognized $5,000 in revenue in the nine months ended September 30, 2016 and $95,925 in revenue in the nine months ended September 30, 2015. Operations have been significantly reduced; the Company sold equipment to our licensee during the nine months of 2016. The Company does not anticipate any future revenue from equipment sales during 2016.

Cost of goods sold

The Company had no cost of goods sold during the nine months ended September 30, 2016 and approximately $68,000 for the nine months ended September 30, 2015.

Selling, general and administrative

Selling, general and administrative expenses decreased to approximately $88,000 for the nine months ended September 30, 2016 from approximately $906,000 for the nine months ended September 30, 2015.

The decrease in selling, general and administrative expenses is principally due to the significant reduction in operating activities which include a decrease in employee expenses of approximately $378,000; a decrease in travel and office expenses of approximately $349,000 which includes commercial insurance, rent and other expenses; a decrease in legal and investor relations expenses of $52,000; a decrease in advertising and promotion of approximately $34,000; and a decrease in bad debt expense of $5,000.

Impairment on assets held for sale

As part of the strategy to keep operations running at minimum capacity, in 2015 we chose to sell assets or return collateralized assets to relieve the debt, which are not critical to the continued operations. We reclassified these non-critical assets for sale from equipment or inventory and recognized an impairment loss when the carrying amount of the assets exceeds its fair value. During the nine months ended September 30, 2015 we recognized an impairment on assets held for sale of approximately $55,000.

Research and Development

The Company had research and development costs during the nine months ended September 30, 2016 of approximately $6,000; a decrease from approximately $24,000 for the nine months ended September 30, 2015, as a result of significant reduction in patent applications being filed thereby reducing the legal fees associated therewith, a decrease in manufacturing research and development costs, and a decrease in consulting fees.

Impairment of intangible asset

Based on our financial condition and the inability to obtain financing; we are unable to pursue the necessary commercialization activities to drive us to profitability. We have therefore estimated no future cash flows related to the intangible assets and have recognized an impairment of intangible assets in the amount of $1,517,859 for the nine months ended September 30, 2015.

Liquidity and capital resources

Overview

We have incurred operating losses, accumulated deficit and negative cash flows from operations since inception. As of September 30, 2016, we had an accumulated deficit of approximately $15,153,000 from operating activities. The Company had total cash on hand including cash from discontinued operations of approximately $10,000 as of September 30, 2016. The Company is not able to obtain additional financing adequate to fulfill its commercialization activities, nor achieve a level of revenues adequate to support the Company’s cost structure.

Operating Activities

During the nine months ended September 30, 2016, the Company used $27,398 in cash for continuing operations and $8,808 for discontinued operations compared to cash used of $569,753 for continuing operations and $256,083 for discontinued operations during the nine months ended September 30, 2015. This decrease in cash used for operating activities was due to the significant reduction in employees and overhead expenses. The Company has had little revenue since inception. The Company does not currently have any revenue under contract nor does it have any immediate sales prospects. The Company has significantly scaled back operations to maintain only a minimal level of operations necessary to support our licensee and look for potential merger candidates. For the nine months ended September 30, 2016, the Company incurred a net loss from continuing operations of approximately $246,000. The operations of Dr. Pave, LLC and Dr. Pave Worldwide, LLC have been discontinued. These business components are included in discontinued operations as of September 30, 2016. It is the Company’s intention to move forward as a public entity and to seek potential merger candidates. If the Company fails to merge or be acquired by another company, we will be required to terminate all operations.

Investing Activities

During the nine months ended September 30, 2016 the Company received $17,000 in cash from the sale of assets held for sale, compared to the use of $1,399 for the purchase of computer equipment in the nine months ended September 30, 2015.

Financing Activities

During the nine months ended September 30, 2016, the Company generated $15,000 in cash from financing activities compared to $821,098 during the nine months ended September 30, 2015. This decrease in cash used for operating activities was due to the Company no longer receiving financial support for the business and operations from their small group of investors. The Company entered into a Senior secured loan agreement on March 23, 2016 with JMW Fund, Richland Fund, and San Gabriel Fund (collectively, the “lenders”) whereby the lenders agreed to loan to the Company up to an aggregate of $2,000,000. The interest rate on the notes is 12% per annum and monthly interest payments are due the first day each month beginning March 1, 2015. The notes mature six months from the date of issuance. If any interest payment remains unpaid in excess of 90 days, and the lender has not declared the entire principal and unpaid accrued interest due and payable, the interest rate on that amount only will be increased to 18% per annum, until the past due interest amount is paid in full. The notes and any future notes under the loan agreement are secured by all of the assets of the Company, including intellectual property rights. Upon the occurrence of an event of default the lenders have the right to foreclose on the assets of the Company. The Company received $15,000 under the Senior secured loan agreement during the nine months ended September 30, 2016.

Based upon the Company’s current financial position and inability to obtain additional financing, we do not believe it will be able to satisfy the mandatory principal payments in 2016 under the $2,000,000 senior secured debt. We will continue to work with the lenders to explore additional extension or conversion options as needed. These notes are secured by all the assets of the Company, including intellectual property rights. We are in default on the notes, our assets may be foreclosed upon.

Cash Requirements

The issues described above raise substantial doubt about our ability to continue as a going concern. We have been solely reliant on raising capital or borrowing funds to maintain our operations. We were able to raise debt and equity financing through the assistance of a small number of our investors who have been substantial participants in its debt and equity offerings since our formation. These investors have chosen not to assist us with our capital raising initiatives. At this time, we are not able to obtain any alternative forms of financing and we will not be able to continue to satisfy our current or long term obligations. We desire to merge or be acquired by another company. If a candidate is not identified we will cease operations all together.

Recent accounting pronouncements

There were no new accounting pronouncements issued during the three and nine months ended September 30, 2016 that had a material impact or are anticipated to have a material impact on our financial position, cash flows or operating results.

Controls and procedures

As filed, 2,239 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of disclosure controls and procedures

Our management, with the participation of our Chief Executive Officer, who also serves as our Chief Financial Officer, has concluded, based on evaluation, as of the end of the period covered by this report, that our disclosure controls and procedures (as defined in Rule 15d-15(e) under the Exchange Act) are (1) not effective to ensure that material information required to be disclosed by us in reports filed or submitted by us under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission due to the material weakness noted below, and (2) lacking design to ensure that material information required to be disclosed by us in such reports is accumulated, organized and communicated to our management, including our principal executive officer and principal financial officer, as appropriated, to allow timely decisions regarding required disclosure.

Material Weakness and Related Remediation Initiatives

Our management concluded that as of September 30, 2016, the following material weaknesses existed: 1. Due to the Company’s budget constraints, the Company’s accounting department does not maintain the number of accounting personnel (either in-house or external) necessary to ensure more complete and effective financial reporting controls. Through the efforts of management, external consultants, and our Director, we have developed a specific action plan to remediate the material weaknesses. Due to the significant reduction in operations, the Company was unable to remediate the material weakness during 2016.

We have fewer than 300 record holders and, thus, our reporting obligations were automatically suspended. As a voluntary filer, we may choose to cease filing Exchange Act reports at any time.

Changes in internal control over financial reporting

There has been no change in our internal control over financial reporting, as defined in Rules 13a-15(f) of the Exchange Act, during the three and nine months ended September 30, 2016, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 125 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

See “Item 1A - Risk Factors” as disclosed in Form 10-K as filed with the Securities and Exchange Commission on June 19, 2017.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue9 months2016-01-01 to 2016-09-30$5.0kus-gaap:Revenues
Gross profit9 months2016-01-01 to 2016-09-30$5.0kus-gaap:GrossProfit
Research and development3 months2016-07-01 to 2016-09-30$574us-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-01-01 to 2016-09-30$6.3kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-07-01 to 2016-09-30$4.4kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2016-01-01 to 2016-09-30$88.2kus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2016-07-01 to 2016-09-30$63.3kus-gaap:InterestExpense
Interest expense9 months2016-01-01 to 2016-09-30$182.1kus-gaap:InterestExpense
Net income3 months2016-07-01 to 2016-09-30−$68.3kus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30−$245.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30−$0.02us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2016-01-01 to 2016-09-30−$36.2kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-09-30$6.7kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$35.2kus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$35.2kus-gaap:Assets
Current liabilitiesAt period end2016-09-30$2.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-09-30$2.3mus-gaap:Liabilities
Shareholders' equityAt period end2016-09-30−$2.2mus-gaap:StockholdersEquity
Shares outstandingAt period end2016-09-3011,017,388 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001393905-17-000272. Last ingested by Listed: Nov 14, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.